Minireviews
Copyright ©The Author(s) 2016.
World J Clin Oncol. Oct 10, 2016; 7(5): 370-379
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.370
Table 1 Additional selected, non-randomized clinical experience with interstitial brachytherapy with more than 5 years follow-up
Ref.No. of patientsFollow-up interval (yr)ModalitySchemeTotal dose (Gy)5-yr LR (%)Good/excellent cosmesis
Strnad et al[57]2745.25PDR/HDRPDR = 0.6 Gy/hPDR = 50 Gy2.9%90%
HDR = 4 Gy × 8HDR = 32 Gy
Rabinovitch et al[32,58]9811.3LDR/HDRLDR = 3.5-5 dLDR = 45 Gy4%68%
HDR = 3.4 Gy × 10HDR = 34 Gy
Shah et al[59,60]19912.0LDR/HDRLDR 0.52 Gy/h × 96 hLDR = 50 Gy5% (12-yr 5%)99%
HDR = 4 Gy × 8HDR = 32 Gy
HDR = 3.4 Gy × 10HDR = 34 Gy
King et al[27]516.25LDR/HDRLDR = 4 dLDR = 45 Gy3.9%75%
HDR = 4 Gy × 8HDR = 32 Gy
Ott et al[61,62]2745.33PDR/HDRPDR = 0.6 Gy/hPDR = 49.8 Gy2.3%92%
HDR = 4 Gy × 8HDR = 32 Gy
Polgár et al[63]4511.1HDR4.33 Gy × 730.3 Gy4.4% (12-yr 9.3%)78%
5.2 Gy × 736.4 Gy